University of Tennessee Health Science Center
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From University of Tennessee Health Science Center
Ventral hernia repair is associated with a relatively high incidence of microbial contamination of the surgical site, ranging from 8% to 40%. To combat infection, Ariste Medical LLC has developed a mid-weight hernia mesh that features a proprietary polymer coating embedded with a programmed release of two proven antimicrobials.
The Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests held its inaugural meeting Aug. 26 to begin work on recommending crosswalks and gapfills for more than 25 molecular tests codes.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Tech Transfer Deals column provides a monthly update on technology transfer deals, reporting licensing agreements between companies and universities or other research institutions within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced March through April 2015.
Clinicians who work with stroke patients are beginning to look at robotics and other innovative technologies in rehabilitation that could allow for more treatments without increasing staffing. Young companies with products in development compete with established players in this market, which eventually could become more important to providers as reform efforts move ahead.
- Academic and Research Institutions